Researchers aim to explore and investigate axonal dysfunction in neurodegeneration
Category: amyotrophic lateral sclerosis
The neurodegenerative disease currently affects more than 200,000 people worldwide
The progressive neurological disorder currently affects more than 200,000 people worldwide
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
The fatal motor neurone disease currently does not have a cure available to treat patients